Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients is a research paper published in Clinical Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: A-017
National Institute of Allergy and Infectious Diseases
Grant: R01AI167272
National Cancer Institute
Grant: 1S10OD011996-01
FACSAria SORP Cell Sorter
National Cancer Institute
Grant: 1S10OD026814-01
5-laser 30-parameter FACSymphony-S6 SORP Cell Sorter from BD Biosciences
National Cancer Institute
Grant: CA060553
NIH HHS
Grant: S10 OD026814
NCATS NIH HHS
Grant: UL1 TR001422
NCI NIH HHS
Grant: P30 CA060553
NCI NIH HHS
Grant: R01 CA232347
NCI NIH HHS
Grant: R01 CA257520
NIH HHS
Grant: S10 OD011996
National Institutes of Health
Grant: 5UL1TR001422-04
Northwestern University Clinical and Translational Science Institute (NUCATS)
National Institutes of Health
Grant: 5R01AI167272-03
Clinical analysis and therapeutic development of exosomal ACE2
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Chicago Biomedical Consortium
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Northwestern University Feinberg School of Medicine
FWCI
5.33
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 5 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 7 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 7 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 8 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 6 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 6 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 8 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 1 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 5 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 3 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 4 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 4 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 1 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 2 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 2 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Additional file 3 of Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer